Literature DB >> 28127378

Effective Response of Methotrexate for Recurrent Idiopathic Hypertrophic Spinal Pachymeningitis.

Tae Joon Park1, Won Deok Seo2, Sang Young Kim1, Jae Hoon Cho1, Dae Hyun Kim1, Ki Hong Kim1.   

Abstract

Idiopathic hypertrophic spinal pachymeningitis (IHSP) is a chronic progressive and diffuse inflammatory fibrosis of the spinal dura mater. Though treatment of IHSP is surgical decompression with steroid therapy, treatment for recurrent IHSP is controversial. Our patient was diagnosed with IHSP based on magnetic resonance imaging (MRI) and underwent laminectomy for decompression following steroid pulse therapy. Despite maintenance of steroid therapy, the patient experienced 3 recurrences. As an alternative immunosuppressant medication, methotrexate was introduced with low-dose steroid. Fortunately, the symptom was resolved, and a decrease of dura thickening was revealed on MRI. We present the case and suggest that methotrexate might be an effective treatment modality for recurrent IHSP.

Entities:  

Keywords:  Methotrexate; Pachymeningitis; Steroid

Year:  2016        PMID: 28127378      PMCID: PMC5266097          DOI: 10.14245/kjs.2016.13.4.200

Source DB:  PubMed          Journal:  Korean J Spine        ISSN: 1738-2262


  19 in total

Review 1.  Idiopathic hypertrophic pachymeningitis: a report of two patients and review of the literature.

Authors:  A S Dumont; A W Clark; R J Sevick; S T Myles
Journal:  Can J Neurol Sci       Date:  2000-11       Impact factor: 2.104

2.  Chronic pachymeningitis; report of a case and review of the literature.

Authors:  H C NAFFZIGER; W E STERN
Journal:  Arch Neurol Psychiatry       Date:  1949-10

Review 3.  Idiopathic hypertrophic spinal pachymeningitis: a case report and review of literature.

Authors:  Li-xia Qin; Chun-yu Wang; Zhi-ping Hu; Liu-wang Zeng; Li-ming Tan; Hai-nan Zhang
Journal:  Eur Spine J       Date:  2015-04-24       Impact factor: 3.134

4.  Idiopathic hypertrophic spinal pachymeningitis.

Authors:  Moksha G Ranasinghe; Omar Zalatimo; Elias Rizk; Charles S Specht; G Timothy Reiter; Robert E Harbaugh; Jonas Sheehan
Journal:  J Neurosurg Spine       Date:  2011-05-13

Review 5.  Recurrence of hypertrophic spinal pachymeningitis. Report of two cases and review of the literature.

Authors:  Zenya Ito; Yoshimitsu Osawa; Yukihiro Matsuyama; Takaaki Aoki; Atsushi Harada; Naoki Ishiguro
Journal:  J Neurosurg Spine       Date:  2006-06

6.  Long-term outcome of idiopathic hypertrophic thoracic pachymeningitis.

Authors:  Mio Tsutsui; Taketoshi Yasuda; Masahiko Kanamori; Takeshi Hori; Tomoatsu Kimura
Journal:  Eur Spine J       Date:  2011-05-19       Impact factor: 3.134

7.  Idiopathic hypertrophic cranial pachymeningitis successfully treated with weekly subcutaneous methotrexate.

Authors:  J L Ruiz-Sandoval; G Bernard-Medina; E J Ramos-Gómez; S Romero-Vargas; S Gutiérrez-Ureña; S González-Cornejo; E Chiquete
Journal:  Acta Neurochir (Wien)       Date:  2006-04-18       Impact factor: 2.216

Review 8.  Idiopathic hypertrophic pachymeningitis.

Authors:  M J Kupersmith; V Martin; G Heller; A Shah; H J Mitnick
Journal:  Neurology       Date:  2004-03-09       Impact factor: 9.910

9.  Idiopathic hypertrophic cranial pachymeningitis.

Authors:  S R Hamilton; C H Smith; S Lessell
Journal:  J Clin Neuroophthalmol       Date:  1993-06

Review 10.  Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature.

Authors:  T Bosman; C Simonin; D Launay; S Caron; A Destée; L Defebvre
Journal:  Rheumatol Int       Date:  2007-12-19       Impact factor: 2.631

View more
  1 in total

1.  Idiopathic Hypertrophic Spinal Pachymeningitis with Spinal Cord Lesion: A Case Report.

Authors:  Jae Yeon Park; Il Choi; Eun Kyung Khil; Wu Jae Kim; Il Young Shin
Journal:  Korean J Neurotrauma       Date:  2020-06-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.